Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page lists revision v3.4.2, replacing v3.4.1, indicating a minor metadata update with no changes to trial data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, a minor version update with no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded 'Multiple myeloma' as a topic and 'MedlinePlus Genetics' as a related topic to the study page.SummaryDifference0.2%

- Check33 days agoChange DetectedGlossary visibility controls (Show glossary and Hide glossary) were added, and the page footer now includes Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Text such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' was removed.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a page revision tag: Revision: v3.3.4, and removed related topics including 'Multiple Myeloma', 'MedlinePlus Genetics', and the prior revision tag 'Revision: v3.3.3'. The primary study details are unaffected.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded related topics: Multiple myeloma and a MedlinePlus Genetics link in the Related Topics section.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.